MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10787-021-00892-x

Медицинская библиотека · Inflammopharmacology · 2021

Myeloperoxidase as an important predictor of cardiovascular risk in individuals with rheumatoid arthritis.

Montes Elisangela Gueiber, Mansani Fabiana Postiglioni, de Oliveira Toledo Júnior Alceu, Schafranski Marcelo Derbli, Zardo Bruno Queiroz, Dos Santos Fábio André, Grassiolli Sabrina, de Freitas Calixto Lorena, da Costa Rômulo Lopes, de Freitas Netto Felício, Vellosa José Carlos Rebuglio

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Rheumatoid arthritis is an inflammatory disease with joint manifestations. In the presence of extra-articular manifestations, the morbidity and severity of the disease increase. Glucocorticoid is used as a treatment and may result in side effects related to cardiovascular risk.

METHODS

This was a cross-sectional study including 59 volunteers with rheumatoid arthritis receiving treatment at a hospital of Campos Gerais that aimed to establish the relation between cardiovascular risk, glucocorticoid treatment and myeloperoxidase in these patients. Subjects were divided into two groups: using (n = 39) and without glucocorticoids (n = 20). They underwent clinical evaluation, physical examination and blood samples were taken. Statistical analysis was performed using Student's t test and Mann-Whitney test. Logistic regression was performed to assess the cardiovascular risk. The significance level was 5% (α = 0.05). Calculations were performed using the Statistical Package for the Social Science version 21.0.

RESULTS

There has been a significant difference between groups in blood glucose values (p = 0.012), which can be explained by the different percentage of diabetic patients in the groups. When assessing cardiovascular risk using the predictors of glucocorticoid dose, time of glucocorticoid use, myeloperoxidase, and C-reactive protein together, these were responsible for significantly predicting this risk (p = 0.015).

CONCLUSION

A significant relation between the predictor myeloperoxidase alone was also demonstrated (p = 0.037), it may be an important predictor of cardiovascular risk among individuals with rheumatoid arthritis.

Для цитирования: Montes Elisangela Gueiber, Mansani Fabiana Postiglioni, de Oliveira Toledo Júnior Alceu, Schafranski Marcelo Derbli, Zardo Bruno Queiroz, Dos Santos Fábio André, Grassiolli Sabrina, de Freitas Calixto Lorena, da Costa Rômulo Lopes, de Freitas Netto Felício, Vellosa José Carlos Rebuglio. Myeloperoxidase as an important predictor of cardiovascular risk in individuals with rheumatoid arthritis.. Inflammopharmacology. 2021. DOI: 10.1007/s10787-021-00892-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.